Know and understand the primary drug classes used to manage Parkinson’s disease including L-Dopa, DA agonists, COMT inhibitors, MAO-B inhibitors, Apomorphine
Level
This learning outcome is a primary level outcome.
Sessions
This learning outcome is taught in the following sessions:
